Preventing local complications of depot neurolepticsBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7016.1368b (Published 18 November 1995) Cite this as: BMJ 1995;311:1368
- Chris Muldoon
- Head of medical department Lundbeck, Caldecotte Lake Business Park, Caldecotte, Milton Keynes MK7 8LF
EDITOR,--Justin Hay's short report on complications at the site of injection of depot neuroleptics raises an important issue affecting those patients who require maintenance treatment with such formulations.1 His conclusion that patients who have developed such complications should avoid certain formulations, including zuclopenthixol concentrate, is not borne out by our experience, both in clinical trials and from spontaneous reports of adverse reactions to the company. Certain aspects of Hay's study may go some way towards …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial